CD8A and neoplasm: MDSCs in colorectal cancer can inhibit cytotoxicity of CD8+ T cells and NK cells by secreting TGF-β, NO and ROS, interrupt B cells from producing antibodies against tumor-associated antigens (TAA), induce Treg cells, and exert immunosuppressive effects in other ways (107).